H.W. Hann

Adefovir dipivoxil (ADV) alone and in combination with lamivudine (LAM) suppresses LAM-resistant hepatitis B virus (HBV) replication: 16 week interim analysis

Marion G. Peters, H.W. Hann, Paul Martin et al. · Journal of Hepatology · 2002 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +16

Continued therapy with ABI-H0731+NRTI results in sequential reduction/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg positive patients

Sulkowski, Kosh Agarwal, SK Fung et al. · Hepatology · 2019 · 13 citations

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +10

744 TENOFOVIR DF (TDF) IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRE-EXISTING MILD RENAL IMPAIRMENT

S. Fung, Peter Kwan, Andrzej Horban et al. · Journal of Hepatology · 2013 · 11 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +11

[49] ENTECAVIR (ETV) RESULTS IN HIGHER HBV-DNA REDUCTION VS ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBeAg(+) ANTIVIRAL-NAIVE ADULTS: 48 WK RESULTS (E.A.R.L. STUDY)

Nancy Leung, Cheng‐Yuan Peng, Jose D. Sollano et al. · Journal of Hepatology · 2007 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

998 ENTECAVIR (ETV) RESULTS IN HIGHER HBV DNA REDUCTION VERSUS ADEFOVIR (ADV) IN ANTIVIRAL-NAIVE HBEAG(+) ADULTS WITH HIGH HBVDNA: WEEK 96 RESULTS (E.A.R.L.Y. STUDY)

Nancy Leung, Cheng‐Yuan Peng, Jose D. Sollano et al. · Journal of Hepatology · 2008 · 10 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13